Antioxidants (Oct 2022)

Identification of Heme Oxygenase-1 as a Putative DNA-Binding Protein

  • Alejandro Scaffa,
  • George A. Tollefson,
  • Hongwei Yao,
  • Salu Rizal,
  • Joselynn Wallace,
  • Nathalie Oulhen,
  • Jennifer F. Carr,
  • Katy Hegarty,
  • Alper Uzun,
  • Phyllis A. Dennery

DOI
https://doi.org/10.3390/antiox11112135
Journal volume & issue
Vol. 11, no. 11
p. 2135

Abstract

Read online

Heme oxygenase-1 (HO-1) is a rate-limiting enzyme in degrading heme into biliverdin and iron. HO-1 can also enter the nucleus and regulate gene transcription independent of its enzymatic activity. Whether HO-1 can alter gene expression through direct binding to target DNA remains unclear. Here, we performed HO-1 CHIP-seq and then employed 3D structural modeling to reveal putative HO-1 DNA binding domains. We identified three probable DNA binding domains on HO-1. Using the Proteinarium, we identified several genes as the most highly connected nodes in the interactome among the HO-1 gene binding targets. We further demonstrated that HO-1 modulates the expression of these key genes using Hmox1 deficient cells. Finally, mutation of four conserved amino acids (E215, I211, E201, and Q27) within HO-1 DNA binding domain 1 significantly increased expression of Gtpbp3 and Eif1 genes that were identified within the top 10 binding hits normalized by gene length predicted to bind this domain. Based on these data, we conclude that HO-1 protein is a putative DNA binding protein, and regulates targeted gene expression. This provides the foundation for developing specific inhibitors or activators targeting HO-1 DNA binding domains to modulate targeted gene expression and corresponding cellular function.

Keywords